drugset / Trial / NCT00284050
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluated the safety and efficacy of ranibizumab on retinal edema and visual acuity in patients with diabetic macular edema with center involvement.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.3 mg | Intravitreal |
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |